Today, we feature our next installment in the Biopharmaceutical Development and Production Podcast series. Our guest is is Jennifer Garner, Senior Engineer, Vaccine Technology Integration of Raw Materials at Merck.During this podcast, she answers the following questions:
- 1. How does/did Merck define “risk” for the supply of purchased raw materials?
- 2. What methodology was used to score risk and compare risk among purchased raw materials?
- 3. What are the limitations of a supply risk assessment?
- 4. What are the next steps after a risk assessment is completed?
Jen will be presenting "Raw Material Reliability: Supply, Compliance and Risk Evaluation Factors," on Tuesday, February 26. For more information on her session and the rest of the Biopharmaceutical Production and Development event, download the agenda. If you'd like to join Jennifer, register today and mention code BDP13JP and you’ll save 20% off the standard rate!*
*This discount only applies if you haven't registered to join us.
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment